Presentation TCT 2013 Anticoagulation and Antiplatelet Regimens After TAVR: Bivalirudin (BRAVO 2/3 Trial) and Other Alternatives Presenter: George Dangas October 28, 2013
Presentation TCT 2013 Institutional Benefits of a CTO Program Presenter: James Hermiller Jr October 28, 2013
Presentation TCT 2013 Editorial Comment: LAA Exclusion: Anatomical Considerations, Device Selection and Outcomes Presenter: Juan Granada October 28, 2013
Presentation TCT 2013 Medical Therapy: Still the First Choice Presenter: Darrel Francis October 28, 2013
Presentation TCT 2013 Triple Therapy (DAPT Plus Chronic Oral Anticoagulation): Risks and Therapeutic Alternatives Presenter: Eugenia Nikolsky October 28, 2013
Presentation TCT 2013 All Bleeding Stops: Tools, Approaches, and Pitfalls in the Management of Bleeding Presenter: Barry Katzen October 28, 2013
Presentation TCT 2013 Case 2: Critical Limb Ischemia with a Six-Week Heel Ulcer (Medial and Lateral) in a 65-Year-Old Diabetic Male Presenter: William Gray October 28, 2013